Item Type | Name |
Academic Article
|
Heritability and expression of C-reactive protein in type 2 diabetes in the Diabetes Heart Study.
|
Academic Article
|
Genetic factors in diabetic nephropathy.
|
Academic Article
|
Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans.
|
Academic Article
|
Target organ damage in African American hypertension: role of APOL1.
|
Academic Article
|
Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy.
|
Academic Article
|
The new era of APOL1-associated glomerulosclerosis.
|
Academic Article
|
Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.
|
Academic Article
|
Association of trypanolytic ApoL1 variants with kidney disease in African Americans.
|
Academic Article
|
The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.
|
Academic Article
|
Intensive blood-pressure control in hypertensive chronic kidney disease.
|
Academic Article
|
Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans.
|
Academic Article
|
Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.
|
Academic Article
|
Insights into the genetic architecture of diabetic nephropathy.
|
Academic Article
|
Novel findings and future directions on the genetics of hypertension.
|
Academic Article
|
Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.
|
Concept
|
Apolipoproteins
|
Concept
|
Apolipoproteins E
|
Academic Article
|
APOL1 and progression of nondiabetic nephropathy.
|
Academic Article
|
APOL1 and nephropathy progression in populations of African ancestry.
|
Academic Article
|
JC polyoma virus interacts with APOL1 in African Americans with nondiabetic nephropathy.
|
Academic Article
|
APOL1 risk variants, race, and progression of chronic kidney disease.
|
Academic Article
|
APOL1 associations with nephropathy, atherosclerosis, and all-cause mortality in African Americans with type 2 diabetes.
|
Academic Article
|
The impact of APOL1, CAV1, and ABCB1 gene variants on outcomes in kidney transplantation: donor and recipient effects.
|
Academic Article
|
Gene-gene interactions in APOL1-associated nephropathy.
|
Academic Article
|
Analysis of coding variants identified from exome sequencing resources for association with diabetic and non-diabetic nephropathy in African Americans.
|
Academic Article
|
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.
|
Academic Article
|
Evaluation of candidate nephropathy susceptibility genes in a genome-wide association study of African American diabetic kidney disease.
|
Academic Article
|
The authors reply:.
|
Academic Article
|
Gene-gene and gene-environment interactions in apolipoprotein L1 gene-associated nephropathy.
|
Academic Article
|
Coding variants in nephrin (NPHS1) and susceptibility to nephropathy in African Americans.
|
Academic Article
|
Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial.
|
Academic Article
|
Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.
|
Academic Article
|
Localization of APOL1 protein and mRNA in the human kidney: nondiseased tissue, primary cells, and immortalized cell lines.
|
Academic Article
|
Should kidney donors be genotyped for APOL1 risk alleles?
|
Academic Article
|
Lack of Association of the APOL1 G3 Haplotype in African Americans with ESRD.
|
Academic Article
|
Apolipoprotein L1-associated nephropathy and the future of renal diagnostics.
|
Academic Article
|
APOL1 G1 genotype modifies the association between HDLC and kidney function in African Americans.
|
Academic Article
|
APOL1 and kidney disease: new insights leading to novel therapies.
|
Academic Article
|
Biogenesis and cytotoxicity of APOL1 renal risk variant proteins in hepatocytes and hepatoma cells.
|
Academic Article
|
Deceased donor multidrug resistance protein 1 and caveolin 1 gene variants may influence allograft survival in kidney transplantation.
|
Academic Article
|
Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
|
Academic Article
|
APOL1 Genotype and Kidney Transplantation Outcomes From Deceased African American Donors.
|
Academic Article
|
Characterization of circulating APOL1 protein complexes in African Americans.
|
Academic Article
|
Deceased-Donor Apolipoprotein L1 Renal-Risk Variants Have Minimal Effects on Liver Transplant Outcomes.
|
Academic Article
|
APOL1 nephropathy risk variants are associated with altered high-density lipoprotein profiles in African Americans.
|
Academic Article
|
APOL1 renal-risk genotypes associate with longer hemodialysis survival in prevalent nondiabetic African American patients with end-stage renal disease.
|
Academic Article
|
APOL1 renal-risk variants associate with reduced cerebral white matter lesion volume and increased gray matter volume.
|
Academic Article
|
APOE Genotypes Associate With Cognitive Performance but Not Cerebral Structure: Diabetes Heart Study MIND.
|
Academic Article
|
APOL1 Renal-Risk Variants Induce Mitochondrial Dysfunction.
|
Academic Article
|
APOL1 Gene Kidney Risk Variants and Cardiovascular Disease: Getting to the Heart of the Matter.
|
Academic Article
|
APOL1 genotype, blood pressure, and survival in African Americans with nondiabetic nephropathy.
|
Academic Article
|
The Apolipoprotein L1 Gene and Cardiovascular Disease.
|
Academic Article
|
A null variant in the apolipoprotein L3 gene is associated with non-diabetic nephropathy.
|
Academic Article
|
A tripartite complex of suPAR, APOL1 risk variants and avß3 integrin on podocytes mediates chronic kidney disease.
|
Academic Article
|
Response to Comment on Chan et al. FGF23 Concentration and APOL1 Genotype Are Novel Predictors of Mortality in African Americans With Type 2 Diabetes. Diabetes Care 2018;41:178-186.
|
Academic Article
|
Plasma apoM and S1P levels are inversely associated with mortality in African Americans with type 2 diabetes mellitus.
|
Academic Article
|
APOL1 and Mortality in Patients on Dialysis.
|